Technical Articles

On the battlefield against cancer, antibody-drug conjugates (ADCs) are emerging as a powerful weapon with "precision-guided" capabilities! Like special forces armed with toxins, they leverage monoclonal antibodies as "guidance systems" to lock onto tumor cells with pinpoint accuracy, delivering cytotoxic drugs directly into the enemy's core for lethal efficacy—all while minimizing collateral damage to healthy cells.